Brief: Alphamab Oncology Posts HY Loss RMB39.9 Million
Aug 23 (Reuters) - Alphamab Oncology 9966.HK :
* HY LOSS RMB39.9 MILLION VERSUS LOSS RMB147.3 MILLION
* HY REVENUE RMB136.5 MILLION VERSUS RMB53.6 MILLION
Source text for Eikon: ID:nHKS8XcnK4
Further company coverage: 9966.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)